Candel Therapeutics, Inc.
← Back to CADL Overview

Candel Therapeutics, Inc. (CADL)

Profitability & Net Margin History

Current Net Margin

Candel Therapeutics, Inc. currently has a net profit margin of .

Financial Fundamentals

CADLQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.03
2025-09-300.00-0.01
2025-06-300.00-0.00
2025-03-310.000.01
2024-12-310.00-0.01
2024-09-300.00-0.01
2024-06-300.00-0.02
2024-03-310.00-0.01
2023-12-310.00-0.01
2023-09-300.00-0.01
2023-06-300.00-0.01
2023-03-310.00-0.01
2022-12-310.00-0.01-16396.77%1162903
2022-09-300.00-0.01-28025.81%1464194
2022-06-300.00-0.00-13383.87%1056452
2022-03-310.00-0.00-2819.35%796774
2021-12-310.000.005148.39%5728387
2021-09-300.00-0.02-52135.48%296129
2021-06-300.00-0.02-55096.77%4065161
2021-03-310.00-0.00-14445.16%1935484
2020-12-310.00-0.01-33800.00%2556129
2020-09-300.00-0.00-8238.71%103871
2020-06-300.00-0.00-9277.42%356129
2020-03-310.00-0.00-5716.13%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.